P&G partners with HP
This article was originally published in The Tan Sheet
Consumer products firm announces $3 bil., 10-year information technology (IT) managed services contract with technology giant HP to manage IT infrastructure, develop applications and provide support for P&G in more than 60 countries, firm says April 11. Final agreement should be reached in mid-May, NyQuil marketer adds...
You may also be interested in...
New drug development is an increasingly communal enterprise. In Vivo examines how one major US academic institution – the University of California at Los Angeles (UCLA) – is expanding its range of research contacts to open new areas of therapy and shorten the transition from bench to the bedside.
Private Company Edition: Last year set a high bar for venture capital, but this year is starting strong. Recent VC mega-deals include $500m for EQRx and $230m-plus for Tessera Therapeutics. Also, BioGeneration Ventures closed a €140m ($170.2m) fund and NewAmsterdam raised a $196m series A.
Teva has launched its generic version of NuvaRing in the US, adding a second rival generic to the market that already includes Amneal, as well as an authorized generic version from Prasco.